5 Days Ago
1 Min Read

What to watch out for in RXRX's upcoming earning report:

+12.03% 24h

Recursion Pharmaceuticals Inc. (RXRX) is reporting earnings on August 12. Lets zoom in on how the stock is performing.

Analysts are estimating RXRX will report an EPS (earnings per share) of -$0.37. Over the last 90 days, analysts have lowered estimates once and raised them once.

As of August 04 shares of RXRX are trading at $9.78. Over the last 52-week period, the price is down -68.9%. A larger move here can mean investors will have a stronger bullish or bearish outlook on the stock.

If you're a bull you'll primarily care about three things. The first is that the reported EPS beat analysts estimates. The second is that the beat is on higher than expected revenues. Third, that the company guides analysts to robust growth going forward. If all check out, the stock should react accordingly.

RXRX bears will be listening for news that the company underperformed the analysts' estimates. After that they'll want to hear about a negative growth story that frames the company's future as one of deceleration or even decline in revenues over the following quarters

Whether you're a bear or bull you'll want to be aware that occasionally a stock's price movement is caused by the analysts' estimates changing from the Q&A call with management, rather than from the earnings report itself. As you see more of these, you'll begin to notice patterns in the runup and rundown of the stock's price.